Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer: a Randomized Controlled Clinical Trial

NCT06325995 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT06325995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06325995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of Hypofractionated Post-prostatectomy Radiotherapy (HYPORT)for Localized Prostate Cancer: a Randomized Controlled Clinical Trial
Lead sponsor
Changhai Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2024
Completion date
February 1, 2031
Enrollment
428 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized prostate cancer